Healthcare Researcher RG+A Names Head of Research

US healthcare researcher RG+A has appointed Ellen Gordon as Senior Vice President, Head of Research.

RG+A offers primary research and consulting for the healthcare industry, advising pharmaceutical, biotechnology, and medical device companies on pricing, market valuation, and strategy formulation. Gordon (pictured) joins with more than twenty years' healthcare and pharmaceutical research experience. During her career, she has held senior positions at national and international research firms, most recently serving as SVP at Fulcrum Research Group. Before this, she was VP of AlphaImpactRX, VP of Market Strategies International, and Director of the Survey Group at Center for Health Studies.

In her new role, Gordon will lead client service and work collaboratively with the research team to uncover insights and develop programs across all of RG+A's client engagements. CEO and founder Roger Green comments: 'As our industry's adoption of RG+A's forecasting methods explodes, Ellen will play a vital role in helping clients derive maximum value from our methods while standardizing training and deliverables. Her expertise in developing research methods and tools will help even more over the next two to three years as we bring our next-generation forecasting products to market'.

Web site: www.thinkrga.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.